We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of GCVRZ yet.

GCVRZ Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2026, worth a combined $1 — unchanged from a quarter earlier.

Fund positioning in GCVRZ was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $1 of Sanofi Contingent Value Rights stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Sanofi Contingent Value Rights positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.